ALBEMARLE CORP

For the period ended Mar 31, 2026. Filed May 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

ALB$94.93-4.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets - March 31, 2026 and December 31,

CONSOLIDATED BALANCE SHEETS

	March 31,	December 31,
	2026	2025
Assets
Current assets:
Cash and cash equivalents	$1,089,809	$1,618,001
Trade accounts receivable, less allowance for credit losses (2026 – $4,580; 2025 – $4,578)	522,715	593,502
Other accounts receivable	136,767	105,110
Inventories	1,346,960	1,179,271
Other current assets	162,932	140,440
Current assets held for sale	—	371,815
Total current assets	3,259,183	4,008,139
Property, plant and equipment, at cost	11,822,899	11,768,840
Less accumulated depreciation and amortization	3,297,806	3,156,429
Net property, plant and equipment	8,525,093	8,612,411
Investments	1,022,707	900,926
Other assets	636,574	647,185
Goodwill	1,488,404	1,499,657
Other intangibles, net of amortization	207,617	214,233
Noncurrent assets held for sale	—	491,660
Total assets	$15,139,578	$16,374,211
Liabilities And Equity
Current liabilities:
Accounts payable to third parties	$677,151	$779,160
Accounts payable to related parties	256,630	134,369
Accrued expenses	452,927	521,831
Current portion of long-term debt	74,628	74,077
Dividends payable	61,456	61,387
Income taxes payable	53,139	35,467
Current liabilities held for sale	—	191,753
Total current liabilities	1,575,931	1,798,044
Long-term debt	1,807,203	3,119,464
Postretirement benefits	45,075	44,744
Pension benefits	115,451	117,361
Other noncurrent liabilities	1,118,508	1,084,892
Deferred income taxes	369,294	368,275
Noncurrent liabilities held for sale	—	59,970
Commitments and contingencies (Note 8)
Equity:
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, authorized – 275,000, issued and outstanding – 117,886 in 2026 and 117,716 in 2025	1,179	1,178
Mandatory convertible preferred stock, Series A, no par value, $1,000 stated value, authorized – 15,000, issued and outstanding – 2,300 in 2026 and 2025	2,235,105	2,235,105
Additional paid-in capital	3,029,667	3,018,213
Accumulated other comprehensive loss	(259,112)	(334,807)
Retained earnings	4,843,335	4,613,676
Total Albemarle Corporation shareholders’ equity	9,850,174	9,533,365
Noncontrolling interests	257,942	248,096
Total equity	10,108,116	9,781,461
Total liabilities and equity	$15,139,578	$16,374,211

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.